These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34132909)

  • 1. Aggressive infantile myofibromatosis with intestinal involvement.
    Römer T; Wagner N; Braunschweig T; Meyer R; Elbracht M; Kontny U; Moser O
    Mol Cell Pediatr; 2021 Jun; 8(1):7. PubMed ID: 34132909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PDGFRB gain-of-function mutations in sporadic infantile myofibromatosis.
    Arts FA; Sciot R; Brichard B; Renard M; de Rocca Serra A; Dachy G; Noël LA; Velghe AI; Galant C; Debiec-Rychter M; Van Damme A; Vikkula M; Helaers R; Limaye N; Poirel HA; Demoulin JB
    Hum Mol Genet; 2017 May; 26(10):1801-1810. PubMed ID: 28334876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case report: rapid and durable response to PDGFR targeted therapy in a child with refractory multiple infantile myofibromatosis and a heterozygous germline mutation of the PDGFRB gene.
    Mudry P; Slaby O; Neradil J; Soukalova J; Melicharkova K; Rohleder O; Jezova M; Seehofnerova A; Michu E; Veselska R; Sterba J
    BMC Cancer; 2017 Feb; 17(1):119. PubMed ID: 28183292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of PDGFRB Mutations With Pediatric Myofibroma and Myofibromatosis.
    Dachy G; de Krijger RR; Fraitag S; Théate I; Brichard B; Hoffman SB; Libbrecht L; Arts FA; Brouillard P; Vikkula M; Limaye N; Demoulin JB
    JAMA Dermatol; 2019 Aug; 155(8):946-950. PubMed ID: 31017643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic limitations and considerations in the imaging evaluation of advanced multicentric infantile myofibromatosis.
    Parikh A; Driscoll CAH; Crowley H; York T; Dachy G; Demoulin JB; Hoffman SB
    Radiol Case Rep; 2020 Nov; 15(11):2440-2444. PubMed ID: 33014229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PDGFRB mutants found in patients with familial infantile myofibromatosis or overgrowth syndrome are oncogenic and sensitive to imatinib.
    Arts FA; Chand D; Pecquet C; Velghe AI; Constantinescu S; Hallberg B; Demoulin JB
    Oncogene; 2016 Jun; 35(25):3239-48. PubMed ID: 26455322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic testing and surveillance in infantile myofibromatosis: a report from the SIOPE Host Genome Working Group.
    Hettmer S; Dachy G; Seitz G; Agaimy A; Duncan C; Jongmans M; Hirsch S; Kventsel I; Kordes U; de Krijger RR; Metzler M; Michaeli O; Nemes K; Poluha A; Ripperger T; Russo A; Smetsers S; Sparber-Sauer M; Stutz E; Bourdeaut F; Kratz CP; Demoulin JB
    Fam Cancer; 2021 Oct; 20(4):327-336. PubMed ID: 32888134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A recurrent PDGFRB mutation causes familial infantile myofibromatosis.
    Cheung YH; Gayden T; Campeau PM; LeDuc CA; Russo D; Nguyen VH; Guo J; Qi M; Guan Y; Albrecht S; Moroz B; Eldin KW; Lu JT; Schwartzentruber J; Malkin D; Berghuis AM; Emil S; Gibbs RA; Burk DL; Vanstone M; Lee BH; Orchard D; Boycott KM; Chung WK; Jabado N
    Am J Hum Genet; 2013 Jun; 92(6):996-1000. PubMed ID: 23731537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of generalized infantile myofibromatosis with sorafenib and imatinib: A case report.
    Bidadi B; Watson A; Weigel B; Oliveira A; Kirkham J; Arndt C
    Pediatr Blood Cancer; 2020 Jun; 67(6):e28288. PubMed ID: 32307894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infantile Myofibromatosis With Intracranial Extradural Involvement and PDGFRB Mutation: A Case Report and Review of the Literature.
    Al Qawahmed R; Sawyer SL; Vassilyadi M; Qin W; Boycott KM; Michaud J
    Pediatr Dev Pathol; 2019; 22(3):258-264. PubMed ID: 30103666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel
    Hassan M; Butler E; Wilson R; Roy A; Zheng Y; Liem P; Rakheja D; Pavlick D; Young LL; Rosenzweig M; Erlich R; Ali SM; Leavey PJ; Parsons DW; Skapek SX; Laetsch TW
    Cold Spring Harb Mol Case Stud; 2019 Oct; 5(5):. PubMed ID: 31645346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in PDGFRB cause autosomal-dominant infantile myofibromatosis.
    Martignetti JA; Tian L; Li D; Ramirez MC; Camacho-Vanegas O; Camacho SC; Guo Y; Zand DJ; Bernstein AM; Masur SK; Kim CE; Otieno FG; Hou C; Abdel-Magid N; Tweddale B; Metry D; Fournet JC; Papp E; McPherson EW; Zabel C; Vaksmann G; Morisot C; Keating B; Sleiman PM; Cleveland JA; Everman DB; Zackai E; Hakonarson H
    Am J Hum Genet; 2013 Jun; 92(6):1001-7. PubMed ID: 23731542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exome sequencing identifies a novel homozygous variant in NDRG4 in a family with infantile myofibromatosis.
    Linhares ND; Freire MC; Cardenas RG; Pena HB; Bahia M; Pena SD
    Eur J Med Genet; 2014; 57(11-12):643-8. PubMed ID: 25241110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal genetic diagnosis of disseminated infantile myofibromatosis: a case report and literature review.
    Lü Y; Jiang Y; Wu H; Qi Q; Zhou X; Guo Q; Hao N; Liu J; Meng H
    BMC Med Genomics; 2023 Aug; 16(1):185. PubMed ID: 37568122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenital myofibromatosis in two siblings.
    Arcangeli F; Calista D
    Eur J Dermatol; 2006; 16(2):181-3. PubMed ID: 16581573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corneal Infantile Myofibromatosis Caused by Novel Activating Imatinib-Responsive Variants in
    Howaldt A; Lenglez S; Velmans C; Schultheis AM; Clahsen T; Matthaei M; Kohlhase J; Vokuhl C; Büttner R; Netzer C; Demoulin JB; Cursiefen C
    Ophthalmol Sci; 2024; 4(3):100444. PubMed ID: 38374928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicentric infantile myofibromatosis with extensive involvement limited to bone.
    Luque-Cabal M; Obregón-Martínez E; Díez-Blanco M; Álvarez-García M; Fernández-Pérez G
    Skeletal Radiol; 2022 Jul; 51(7):1503-1510. PubMed ID: 34865192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Sunitinib and Other Kinase Inhibitors on Cells Harboring a
    Sramek M; Neradil J; Macigova P; Mudry P; Polaskova K; Slaby O; Noskova H; Sterba J; Veselska R
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30200486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infantile Myofibromatosis With Cutaneous, Visceral, and CNS Involvement: A Multimodal Approach to Therapy.
    Gehle S; Quinsey C; McShane D; Thompson P; Quezada G
    J Pediatr Hematol Oncol; 2023 Oct; 45(7):e921-e923. PubMed ID: 37526359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The spectrum of infantile myofibromatosis includes both non-penetrance and adult recurrence.
    Murray N; Hanna B; Graf N; Fu H; Mylène V; Campeau PM; Ronan A
    Eur J Med Genet; 2017 Jul; 60(7):353-358. PubMed ID: 28286173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.